Table 1 Patient and tumor characteristic (n = 252)
Characteristics | N° Patients (%) |
|---|---|
Stage | |
≤ T2a | 36 (14%) |
T2b | 58 (23%) |
≥ T2c | 158 (63%) |
Geason score: | |
≤ 6 | 109 (43%) |
= 7 | 77 (31%) |
> 7 | 66 (26%) |
Pretreatment PSA (ng/ml) | |
≤ 10 | 44 (17%) |
10.1-20 | 101 (40%) |
> 20 | 107 (43%) |
Mean:20/Median 18 (2.05-59.60) | |
Adjuvant hormonal ablation | |
Yes | 173 (69%) |
No | 79 (31%) |
Age at diagnosis (yr) | |
≤ 60 | 32 (13%) |
61-70 | 131 (52%) |
> 70 | 89 (35%) |
Risk Level | |
High Risk by Gleason y/o PSA | 187 (74%) |
High Risk by T | 65 (26%) |
No. Prognostic factors | |
2 intermediate Risk Criteria | 44 (17%) |
1 High Risk Criteria | 100 (40%) |
2 High Risk Criteria | 89 (35%) |
> 2 Risk Criteria | 19 (8%) |
Gland Vol. Implant (cc): Mean:34/Median 31 (9-87) |